At Gen Re, we believe that information and collaboration are the basis for great innovation.

We leverage the actuarial, medical, and underwriting expertise of our global units with the market-specific knowledge of our regional departments to support your product initiatives.

Our product development support comprises a wide range of services needed by primary insurers, including design of new products, calculation of the respective rates, and development of policy terms and conditions. Post-launch, our portfolio monitoring and experience studies offer additional valuable insights.

Our Products

Card Image


Card Image


Card Image


Card Image

Critical Illness/
Dread Disease

Card Image


Card Image

Long Term Care

Our Services


Our competent advice, comprehensive services, and effective tools and resources guide your risk management decisions.

Learn More


Our team of expert claim professionals develop effective claims management strategies specific to our clients’ needs.

Learn More

Market Research & Surveys

We produce marketplace surveys for our clients and the insurance industry. Clients also benefit from our individualized services including business monitoring.

Learn More


We have a global network of data scientists, and deep expertise in solving complex business problems.

Learn More

Recent Research

Understanding Breast Cancer in Asia – Awareness and the Importance of Screening
Breast cancer ranks as the most prevalent cancer worldwide, and a staggering 2.3 million women were diagnosed with the illness globally in 2020. Although the prospects of survival in the battle against breast cancer are improving, the financial burden on patients remains significant. CI benefits can assist with managing the expenses.
Wendy Low, Pei Nee Yong, Samuel Lim
Morbidity Trends – The Long-Term Impact of the Pandemic [Video]
Long COVID’s persistent symptoms, varying from fatigue to organ damage, challenge diagnosis and treatment, affecting many post-recovery. Its impact on work capacity raises concerns for the labor market and disability insurance, with evidence of reduced work schedules and increased unemployment.
Sabrina Link
Group Term Life – Results of 2023 U.S. Market Survey
Sharing results of the latest Gen Re Group Term Life Market Survey, which also covers the Accidental Death and Dismemberment industry. Twenty-six carriers participated in this year’s survey that tracked sales, inforce results, lapse rate, and employee-paid data.
Nicole Conti
Individual Disability – Results of 2023 U.S. Market Survey
Sharing results of the latest Gen Re Individual Disability Market Survey. This year’s benchmarking survey covers Non-Cancelable, Guaranteed Renewable, Buy-Sell and Guaranteed Standard Issue product lines for 2022 and 2023. Seventeen carriers participated in the survey representing $5.4 billion of inforce premium.
Lisa Bolduc
Ushering in a New Era of Cystic Fibrosis Management
It has long been thought that cystic fibrosis is a pediatric disorder but has become a chronic disease to be managed into adulthood. A “new era” in cystic fibrosis care has been announced, however concerns are that these striking innovations will not be available or affordable across all markets.
Dr. Chris Ball

Find an Expert in Your Region